Jacobs Levy Equity Management, Inc Intra Cellular Therapies, Inc. Transaction History

Jacobs Levy Equity Management, Inc

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2020 Nov 16, 2020	SELL	$17.61 - $31.86 $215,828 - $390,476	-12,256 Closed	0 $0
Q1 2020 May 15, 2020	SELL	$12.31 - $33.12 $2.54 Million - $6.83 Million	-206,159 Reduced 94.39%	12,256 $188,000
Q4 2019 Feb 14, 2020	BUY	$7.26 - $38.49 $148,742 - $788,583	20,488 Added 10.35%	218,415 $7.49 Million
Q3 2019 Nov 14, 2019	BUY	$7.47 - $14.03 $606,885 - $1.14 Million	81,243 Added 69.63%	197,927 $1.48 Million
Q2 2019 Aug 13, 2019	BUY	$10.65 - $14.29 $75,615 - $101,459	7,100 Added 6.48%	116,684 $1.52 Million
Q1 2019 May 14, 2019	BUY	$10.9 - $14.09 $409,513 - $529,361	37,570 Added 52.17%	109,584 $1.34 Million
Q4 2018 Feb 14, 2019	BUY	$10.36 - $20.96 $635,990 - $1.29 Million	61,389 Added 577.78%	72,014 $820,000
Q3 2018 Nov 14, 2018	SELL	$17.77 - $22.9 $40,782 - $52,555	-2,295 Reduced 17.76%	10,625 $231,000
Q2 2018 Aug 14, 2018	BUY	$17.33 - $23.4 $223,903 - $302,328	12,920 New	12,920 $228,000
Q1 2018 May 15, 2018	SELL	$15.16 - $25.49 $254,233 - $427,467	-16,770 Closed	0 $0
Q4 2017 Feb 13, 2018	BUY	$14.27 - $16.79 $72,777 - $85,629	5,100 Added 43.7%	16,770 $243,000
Q3 2017 Nov 14, 2017	BUY	$10.77 - $22.1 $125,685 - $257,907	11,670	11,670 $184,000

378

84.1M

319K

143K

Ticker ITCI
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 94,401,696
Market Cap $7.86B
Description
Intra-Cellular Therapies, Inc., a biopharmaceutical company, develops novel drugs for the treatment of neuropsychiatric and neurologic diseases by targeting intracellular signaling mechanisms within the central nervous system in the United States. The company offers CAPLYTA for the treatment of schizophrenia in adults. It is also involved in dev...

Get notified when there are updates to the investment portfolio of Jacobs Levy Equity Management, Inc, based on Form 13F filings with the SEC.

Stay updated on Jacobs Levy Equity Management, Inc with notifications on news.